155 related articles for article (PubMed ID: 30981590)
1. Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging.
Saita A; Lughezzani G; Buffi NM; Hurle R; Nava L; Colombo P; Diana P; Fasulo V; Paciotti M; Elefante GM; Lazzeri M; Guazzoni G; Casale P
Eur Urol; 2020 Jun; 77(6):727-732. PubMed ID: 30981590
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
Panebianco V; De Berardinis E; Barchetti G; Simone G; Leonardo C; Grompone MD; Del Monte M; Carano D; Gallucci M; Catto J; Catalano C
Eur Radiol; 2017 Sep; 27(9):3759-3766. PubMed ID: 28181054
[TBL] [Abstract][Full Text] [Related]
4. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
5. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study.
Bryan RT; Liu W; Pirrie SJ; Amir R; Gallagher J; Hughes AI; Jefferson KP; Knight A; Nanton V; Mintz HP; Pope AM; Catto JWF; Patel P; James ND
Eur Urol; 2021 Jul; 80(1):12-15. PubMed ID: 33653635
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
[TBL] [Abstract][Full Text] [Related]
7. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G
Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
[TBL] [Abstract][Full Text] [Related]
8. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.
Barentsz JO; Jager GJ; Witjes JA; Ruijs JH
Eur Radiol; 1996; 6(2):129-33. PubMed ID: 8797968
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations.
Hensley PJ; Panebianco V; Pietzak E; Kutikov A; Vikram R; Galsky MD; Shariat SF; Roupret M; Kamat AM
Eur Urol Oncol; 2022 Aug; 5(4):403-411. PubMed ID: 35581143
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
Xu X; Zhang X; Tian Q; Wang H; Cui LB; Li S; Tang X; Li B; Dolz J; Ayed IB; Liang Z; Yuan J; Du P; Lu H; Liu Y
J Magn Reson Imaging; 2019 May; 49(5):1489-1498. PubMed ID: 30252978
[TBL] [Abstract][Full Text] [Related]
11. Staging bladder carcinoma by three-dimensional ultrasound rendering.
Wagner B; Nesslauer T; Bartsch G; Hautmann RE; Gottfried HW
Ultrasound Med Biol; 2005 Mar; 31(3):301-5. PubMed ID: 15749550
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
13. [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
Zhao SM; Yang TJ; Xu CM; Guo XF; Ma YK; Chen XJ; Li X; He CH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):701-704. PubMed ID: 32773805
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
Wang F; Wu LM; Hua XL; Zhao ZZ; Chen XX; Xu JR
J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of novel endoluminal ultrasonography and conventional transurethral ultrasonography in staging of bladder cancer.
Saga Y; Numata A; Tokumitsu M; Yamaguchi S; Fujii H; Hashimoto H; Kaneko S; Yachiku S
Int J Urol; 2004 Aug; 11(8):597-601. PubMed ID: 15285748
[TBL] [Abstract][Full Text] [Related]
16. Comparison of magnetic resonance imaging with computed tomography and intravesical ultrasound in staging bladder cancer.
Salo JO; Kivisaari L; Lehtonen T
Urol Radiol; 1988; 10(4):167-72. PubMed ID: 3072748
[TBL] [Abstract][Full Text] [Related]
17. Transurethral ultrasonographic assessment of bladder carcinoma: its value and limitation.
Koraitim M; Kamal B; Metwalli N; Zaky Y
J Urol; 1995 Aug; 154(2 Pt 1):375-8. PubMed ID: 7609101
[TBL] [Abstract][Full Text] [Related]
18. High-frequency endoluminal ultrasonography for staging transitional cell carcinoma of the bladder.
Horiuchi K; Tsuboi N; Shimizu H; Matsuzawa I; Kimura G; Yoshida K; Akimoto M
Urology; 2000 Sep; 56(3):404-7. PubMed ID: 10962303
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and Specificity of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Bladder Cancers.
Zhai N; Wang YH; Zhu LM; Wang JH; Sun XH; Hu XB; Li X; Yu T; Wang XL; Meng N; Yan QC; Li XJ; Luo YH
Clin Invest Med; 2015 Aug; 38(4):E173-84. PubMed ID: 26278427
[TBL] [Abstract][Full Text] [Related]
20. Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach.
Zheng J; Kong J; Wu S; Li Y; Cai J; Yu H; Xie W; Qin H; Wu Z; Huang J; Lin T
Cancer; 2019 Dec; 125(24):4388-4398. PubMed ID: 31469418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
